Paper9044843
Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes.
Duncan JR and 3 others. Cancer Res, 1997. Cited by 91 papers, by iCite.
Cite this record
ConductScience Library. Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes. Papers, record 9044843. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9044843
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Indium Radioisotopes | Major topic |
| Kidney Neoplasms | Major topic |
| Liver | Major topic |
| Lysosomes | Major topic |
| Octreotide | Major topic |
| Pancreas | Major topic |
| Pancreatic Neoplasms | Major topic |
| Pentetic Acid | Major topic |
| Animals | |
| Female | |
| Radionuclide Imaging | |
| Rats | |
| Rats, Sprague-Dawley | |
| Tissue Distribution |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R29CA64475 | NCI NIH HHS | United States | R29CA064475 | PubMed and NIH |
Source NIH RePORTER
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35207193 | Early Complications of Radioisotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms-A Preliminary Study. | J Clin Med | 2022 | https://conductscience.org/library/papers/35207193 | PubMed |
| 33632272 | Radiation-induced kidney toxicity: molecular and cellular pathogenesis. | Radiat Oncol | 2021 | https://conductscience.org/library/papers/33632272 | PubMed |
| 31903131 | Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics. | Theranostics | 2020 | https://conductscience.org/library/papers/31903131 | PubMed |
| 29488080 | Hyperkalemia in patients treated with endoradiotherapy combined with amino acid infusion is associated with severe metabolic acidosis. | EJNMMI Res | 2018 | https://conductscience.org/library/papers/29488080 | PubMed |
| 27515447 | Nephroprotective effects of enalapril after [177Lu]-DOTATATE therapy using serial renal scintigraphies in a murine model of radiation-induced nephropathy. | EJNMMI Res | 2016 | https://conductscience.org/library/papers/27515447 | PubMed |
| 26664643 | Easy access to heterobimetallic complexes for medical imaging applications via microwave-enhanced cycloaddition. | Beilstein J Org Chem | 2015 | https://conductscience.org/library/papers/26664643 | PubMed |
| 25973333 | Dosimetry of [(177)Lu]-DO3A-VS-Cys(40)-Exendin-4 - impact on the feasibility of insulinoma internal radiotherapy. | Am J Nucl Med Mol Imaging | 2015 | https://conductscience.org/library/papers/25973333 | PubMed |
| 20182713 | A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues. | Eur J Nucl Med Mol Imaging | 2010 | https://conductscience.org/library/papers/20182713 | PubMed |
| 19915842 | Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues. | Eur J Nucl Med Mol Imaging | 2010 | https://conductscience.org/library/papers/19915842 | PubMed |
| 19397856 | Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide. | Mol Imaging | 2009 | https://conductscience.org/library/papers/19397856 | PubMed |
| 19326173 | Replacing 99mTc with 111In improves MORF/cMORF pretargeting by reducing intestinal accumulation. | Mol Imaging Biol | 2009 | https://conductscience.org/library/papers/19326173 | PubMed |
| 16568203 | [(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tate. | Eur J Nucl Med Mol Imaging | 2006 | https://conductscience.org/library/papers/16568203 | PubMed |
| 16151771 | [123I]Mtr-TOCA, a radioiodinated and carbohydrated analogue of octreotide: scintigraphic comparison with [111In]octreotide. | Eur J Nucl Med Mol Imaging | 2006 | https://conductscience.org/library/papers/16151771 | PubMed |
| 16021448 | 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy. | Eur J Nucl Med Mol Imaging | 2005 | https://conductscience.org/library/papers/16021448 | PubMed |
| 15991301 | Somatostatin receptor subtype 2-mediated scintigraphy and localization using (99m)Tc-HYNIC-Tyr(3)-octreotide in human hepatocellular carcinoma-bearing nude mice. | World J Gastroenterol | 2005 | https://conductscience.org/library/papers/15991301 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9044843
GET https://conductscience.org/api/papers/v1/9044843/authors